Amendment: Principal Financial Officer Choudhury Mahesh bought $18,547 worth of shares (2,637 units at $7.03), increasing direct ownership by 8% to 37,192 units (SEC Form 4)
4/A - ConnectM Technology Solutions, Inc. (0001895249) (Issuer)
- Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the pricing of an underwritten public offering of 20,588,236 common shares, without par value, at a public offering price of $34.00 per common share. The gross proceeds to Definium from the offering, before deducting underwriting discounts, commissions, and other offering-related expenses, are expected to be approximately $700 million. In addition, Definium has granted the underwriters an option for a period of 30 days to purchase up
- Director Fairmount Funds Management Llc converted options into 666,680 shares and sold $399,658,667 worth of shares (4,684,781 units at $85.31) (SEC Form 4)
4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
- Amendment: Chief Executive Officer Panigrahi Bhaskar bought $23,143 worth of shares (3,359 units at $6.89), increasing direct ownership by 2% to 150,826 units (SEC Form 4)
4/A - ConnectM Technology Solutions, Inc. (0001895249) (Issuer)
- SEC Form 4 filed by Director Sousa Mauad Bruno
4 - Aura Minerals Inc. (0001468642) (Issuer)
- Amendment: New insider Sousa Mauad Bruno claimed ownership of 615,357 shares (SEC Form 3)
3/A - Aura Minerals Inc. (0001468642) (Issuer)
- Director Henderson Michael Thomas sold $2,000,000 worth of shares (20,000 units at $100.00) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 68,606 units (SEC Form 4)
4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
- President, CEO & Chairman Selwyn Joffe converted options into 66,432 shares, increasing direct ownership by 12% to 630,535 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- VP, Gen Counsel and Secretary Stone Juliet Lynn converted options into 5,442 shares, increasing direct ownership by 16% to 38,838 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- New insider Ajello James A claimed ownership of 52,244 shares (SEC Form 3)
3 - HAWAIIAN ELECTRIC INDUSTRIES INC (0000354707) (Issuer)
- VP, General Counsel & Sec. Burlingame Glenn Daniel converted options into 5,176 shares, increasing direct ownership by 340% to 6,700 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.76% to 276,420 units (SEC Form 4) to satisfy tax liability
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Chief Manufacturing Officer Schooner Douglas Earl converted options into 6,758 shares, increasing direct ownership by 19% to 42,465 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- Chief Accounting Officer Humes Jennifer covered exercise/tax liability with 3,582 shares, decreasing direct ownership by 3% to 109,782 units (SEC Form 4) (for withholding tax)
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Director Orsel Karin Y
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- Director Das Paramita converted options into 9,554 shares (SEC Form 4)
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- SEC Form 4 filed by Director Regan Arthur L
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)